Filing Flows › Longevity Health Holdings (XAGE) › Q4 2024
Longevity Health Holdings (XAGE) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 31, 2025
Longevity Health Holdings (XAGE) reported revenue of $17K for the fourth quarter 2024 (Q4 2024) and -15% from the quarter before.
Longevity Health Holdings, Q4 2024: revenue $17K, net loss $914K, operating cash flow −$772K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17K | -15% | — |
| Operating profit | −$1.0M | — | — |
| Net earnings | −$914K | — | — |
| Operating cash flow | −$772K | — | — |
What changed
Revenue was $17K in Q4 2024, down 15% from the previous quarter.
Gross margin was 93.0%. Operating costs exceeded revenue by $1.0M, an operating margin of -5760.5%. The quarter ended with a net loss of $914K, narrower than the previous quarter's $2.9M loss.
Operating cash flow was −$772K. Non-cash charges added back $18K of depreciation and amortization and $266K of share-based compensation. Working capital and other items used $142K.
Questions
What was Longevity Health Holdings' revenue in the fourth quarter 2024?
Longevity Health Holdings (XAGE) reported revenue of $17K for the fourth quarter 2024 (Q4 2024) and -15% from the quarter before.